Hepatotropic viruses in the Brazilian Amazon: A health threat

Brazilian Journal of Infectious Diseases

Volumn 12, Issue 3, 2008, Pages 253-256

  Paraná, Raymundo ^a,d   Vitvitski, Ludmila ^b   Pereira, Joao Eduardo ^c  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b INSERM   (France)

^c DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

^d NONE   (Brazil)

Author keywords

Amazonian; Brazil; Hepatitis viruses; South America

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; ENTECAVIR; HEPATITIS B VACCINE; INTERFERON; LAMIVUDINE; PEGINTERFERON; RIBAVIRIN; TENOFOVIR;

BRAZIL; CLINICAL STUDY; CULTURAL FACTOR; DEMOGRAPHY; DRUG COST; ENVIRONMENTAL FACTOR; ETHNICITY; GENOTYPE; HEALTH HAZARD; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER DISEASE; PATHOGENESIS; PREVALENCE; REVIEW; SOUTH AMERICA; VIRUS HEPATITIS;

EID: 54349102597     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702008000300017     Document Type: Review

References (33)

1. Brasil. Ministério da Saúde/Programa Nacional de Hepatites Virais., Hepatites Virais: O Brasil está Atento. 2002.
2. de Paula V.S., Arruda M.E., Vitral C.L., Gaspar A.M. Seroprevalence of viral hepatitis in riverine communities from the Western Region of the Brazilian Amazon Basin. Mem Inst Oswaldo Cruz 2001;96(8):1123-8.
3. Fried M.W. Clinical application of hepatitis C virus genotyping and quantitation. Clin liver Dis 1997;1(3):631-46.
4. Nakano T., Shapiro C.N., Hadler S.C., et al. Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela. Gen Virol 2001;82:2183-9.
5. Hui A.Y., Chan H.L., Cheung A.Y., et al. Systematic review: treatment of chronic hepatitis B virus infection by pegylated interferon. Aliment Pharmacol Ther 2005;22(6):519-28.
6. Braga W.S., Brasil L.M., Souza R.A., et al. The occurrence of hepatitis B and delta virus infection within seven Amerindian ethnic groups in the Brazilian wesiern Amazon. Rev Soc Bras Med Trop 2001;34:349-55.
7. Tavares-Neto J., Almeida D., Soares M.C., et al. Seroprevalence of hepatitis B and C in the Western Brazilian Amazon region (Rio Branco, Acre): a pilot study carried out during a hepatitis vB accination program. Braz J Infect Dis 2004;8(2):133-9.
8. Brasil. Ministério da Saúde/Gerância de Doenqas Emergentes e Reemergentes. Vigilância das Síndromes Febris let6ricas e/ou Hemorrágicas Agudas: A Experiência Brasileira. Relatório de atividades apresentado a OPAS. 2002.
9. Viana S., Parana R., Moreira R.C., et al. Prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Am J Trop Med Hyg 2005;73(4):808-14.
10. Lobato C., Tavares-Neto J., Rios-Leite M., et al. Intrafamilial prevalence of hepatitis B virus in Western Brazilian Amazon region: epidemiologic and biomolecular study. J Gastroenterol Hepatol 2006 May;21(5):863-8.
11. Parana R., Kay A., Molinet F., et al. HDV genotypes in the Western Brazilian Amazon region: A preliminary report. Am J Trop Med Hyg 2006;75(3):475-9.
12. Silva L., Parana R., Mota E., et al. Prevalence of hepatitis C virus in urban and rural populations of northeast Brazil-pilot study. Arq Gastroenterol 1995;32(4):168-71.
13. Tiago Paiva, José Tavares-Neto, Márcio Rio-Leite, et al. HCV infection in health professionals from Western Brazilian Amazonia. Am J Trop Med Hyg 2007;[in press].
14. Parana R., Abneida D. HBV epidemiology in Latin America. J Clin Virol 2005;34 Suppl 1:S130-3.
15. Bensabath G, Dias L.B. [Labrea hepatitis (Labrea black fever) and other fulminant forms of hepatitis in Sena Madureira, Acre and Boca do Acre, Amazonas, Brazil]. Rev last Med Trop Sao Paulo 1983;25(4):182-94.
16. Fonseca J.C. [Hepatitis D]. Rev Soc Bras Med Trop 2002; 35(2):181-90.
17. Gaeta GB., Stroffolini T., Chiaramonte M., et al. Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology 2000; 32(4 Pt 1):824-7.
18. Ribeiro L.C., Souto F.J. [Hepatitis Delta in the State of Mato Grosso, Brazil: report of 5 cases]. Rev Soc Bras Med Trop 2000; 33(6):599-602.
19. Figueiredo G, Barbosa J. Hepatites Virais: o Brasil está atento. Gazeta Mádica da Bahia 2006;1(76)Sup1:1-4.
20. Casey J.L., Brown T.L., Colan E.J., et al. A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci U S A 1993;90(19):9016-20.
21. Quintero A., Uzcategui N., Loureiro C.L., et al. Hepatitis delta virus genotypes I and III circulate associated with hepatitis B virus genotype F In Venezuela. J Med Virol 2001;64(3):356-9.
22. Manock S.R., Kelley P.M., Hyams K.C., et al. An outbreak of fulminant hepatitis delta in the Waorani, an indigenous people of the Amazon basin of Ecuador. Am J Trop Hyg 2000;63(34):209-13.
23. Bensabath G, Hadler S.C., Soares M.C., et al. Hepatitis delta virus infection and Labrea hepatitis. Prevalence and role in fulminant hepatitis in the Amazon Basin. JAMA 1987;258(4):479-83.
24. Lesbordes J.L., Ravisse P., Georges A.J., et al. Studies on the role of HDV in an outbreak of fulminant hepatitis in Bangui(Central African Republic). Prog Clin Biol Res 1987;234:451-9.
25. Lesbordes J.L., Ravisse P., Georges A.J., et al. [Role of delta viruses in fulminating hepatitis in Central Africa] Ann Med Interne (Paris) 1987;138(3):199-201.
26. Andrade Z.A., Lesbordes J.L., Ravisse P., et al. Fulminant hepatitis with microvesicular steatosis (a histologic comparison of cases occuring in Brazil - Labrea hepatitis - and central Africa - Bangui hepatitis). Rev Soc Bras Med Trop 1992;25:155-60.
27. Casey J.L., Niro G.A., Engle R.E., et al. Hepatitis B virus (HBV)/ hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F. J Infect Dis 1996;174(5):920-6.
28. Tang J.R., Hantz O., Vitvitski L., et al. Discovery of a novel point mutation changing the HDAg expression of a hepatitis delta virus isolate from Central African Republic. J Gen Virol 1993;74(Pt 9):1827-35.
29. Paraná R., Gerard, F., Lesbordes J.L., et al.. Serial transmission of spongiocytic hepatitis to woodchucks (a possible association with a specific delta strain). J Hepatol 1995; 22:468-73.
30. Santantonio T., Mazzola M., Pastore G, Lamivudine is safe and effective in fulminant hepatitis B. J Hepatol 1999;30(3):551.
31. Livingston S.E., Simonetti J.P., McMahon B.J., et al. Hepatitis B virus genotypes in Alaska native people with hepatocelular carcinoma: preponderance of genotype f. J Infect Dis. 2007;195(1):5-11. Epub 2006 Nov 21.
32. Miranda E.C., Moia L. de J., Amaral Ido S., et al. Hepatitis B and C virus infection and the hepatocellular carcinoma in the East Amazon, Brazil. Rev Soc Bras Med Trop 2004;37 Suppl 2:47-51.
33. Gish R.G., Gadano A.C. Chronic Hepatitis B: current epidemiology in the Americas and implications for management. J Vir Hepatitis 2006; 13:787-98.